Patents Assigned to EPAX AS
-
Patent number: 11992474Abstract: The present application relates to compositions for treatment of eye disorders, particularly for treatment of dry eye disease (DED) and meibomianitis, wherein the composition comprises very long chain polyunsaturated fatty acids. Further, the invention provides a method for treatment of DED and meibomianitis of a subject, comprising administering to the subject a composition comprising very long chain polyunsaturated fatty acids derived from natural oils. The compositions for use are suitable for oral and local applications.Type: GrantFiled: June 19, 2019Date of Patent: May 28, 2024Assignee: EPAX NORWAY ASInventors: Harald Breivik, Harald Svensen, Iren Merete Skjåstad Stoknes
-
Publication number: 20210361606Abstract: The present application relates to compositions for treatment of eye disorders, particularly for treatment of dry eye disease (DED) and meibomianitis, wherein the composition comprises very long chain polyunsaturated fatty acids. Further, the invention provides a method for treatment of DED and meibomianitis of a subject, comprising administering to the subject a composition comprising very long chain polyunsaturated fatty acids derived from natural oils. The compositions for use are suitable for oral and local applications.Type: ApplicationFiled: June 19, 2019Publication date: November 25, 2021Applicant: Epax Norway ASInventors: Harald BREIVIK, Harald SVENSEN, Iren Merete Skjåstad STOKNES
-
Patent number: 10501704Abstract: A method of producing a composition comprising a high concentration of very long chain polyunsaturated fatty acids (VLCPUFAs) from natural oils such as fish oil, squid oil, algal oil and krill oil. In addition, a composition comprising a high concentration of very long chain polyunsaturated fatty acids isolated from such natural sources; as well as to a process for isolating separate fractions of very long chain polyunsaturated fatty acids having identical chain lengths but different degrees of unsaturation from such highly concentrated compositions is disclosed.Type: GrantFiled: May 12, 2016Date of Patent: December 10, 2019Assignee: EPAX NORWAY ASInventors: Harald Breivik, Harald Svensen
-
Patent number: 10119098Abstract: An enzymatic process for the kinetic separation of alkyl esters under organic solvent free conditions is disclosed. Alkyl esters obtained from e.g. fish oil are reacted with glycerol, in the presence of water, at different rates in an evacuated chamber. The reaction is terminated prior to reaching equilibrium and the enriched alkyl ester fraction is isolated from the reaction mixture by short path distillation.Type: GrantFiled: May 23, 2006Date of Patent: November 6, 2018Assignee: EPAX NORWAY ASInventors: Per Christian Saebo, Inge Bruheim, Daniele Mancinelli, Asgeir Saebo
-
Publication number: 20180163156Abstract: A method of producing a composition comprising a high concentration of very long chain polyunsaturated fatty acids (VLCPUFAs) from natural oils such as fish oil, squid oil, algal oil and krill oil. In addition, a composition comprising a high concentration of very long chain polyunsaturated fatty acids isolated from such natural sources; as well as to a process for isolating separate fractions of very long chain polyunsaturated fatty acids having identical chain lengths but different degrees of unsaturation from such highly concentrated compositions is disclosed.Type: ApplicationFiled: May 12, 2016Publication date: June 14, 2018Applicant: Epax Norway ASInventors: Harald BREIVIK, Harald SVENSEN
-
Patent number: 9476008Abstract: A process for separating polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) from less saturated long chain fatty acids (LCFAs) in a lipid composition, wherein said PUFAs and LCFAs are present as (i) triglycerides, or (ii) free fatty acids or monoalkyl esters, by exchange of at least a portion of LCFAs with short and/or medium chain fatty acids (MCFAs). The process can suitably be employed on marine derived oil, marine oil 2 derived oil products and other sources of PUFAs, including PUFA-rich singe cell oils (SCOs), and oils from genetically modified organisms with a modified lipid metabolism. The inventive process is based on novel use of lipases and distillation techniques, selectively chemically modifying species in the substrate material such that the desired species and chemically similar species become sufficiently dissimilar to be separable.Type: GrantFiled: June 23, 2011Date of Patent: October 25, 2016Assignee: Epax ASInventors: Gudmundur G. Haraldsson, Bjorn Kristinsson
-
Patent number: 9301536Abstract: The present invention relates to compositions suitable for improving oxidative stability of marine oils, marine oils having improved oxidative stability as well as methods for manufacturing such compositions.Type: GrantFiled: August 26, 2009Date of Patent: April 5, 2016Assignee: Epax Norway ASInventors: Harald Breivik, Charlotte Jacobsen, Vidar Moen, Tanja Vojnovic
-
Publication number: 20150284312Abstract: In one aspect, the present invention is directed to a method for obtaining an enriched composition of long chain monounsaturated fatty acids from an oil composition, typically a fish oil composition, comprising both long chain monounsaturated fatty acids and long chain polyunsaturated fatty acids. In another aspect, the present invention is directed to a composition comprising at least 70% by weight of long chain monounsaturated fatty acids.Type: ApplicationFiled: March 24, 2015Publication date: October 8, 2015Applicant: EPAX NORWAY ASInventors: Harald Breivik, Tanja Vojnovic
-
Publication number: 20130196393Abstract: A process for separating polyunsaturated fatty acids (PUFAs) such as docosahexaenoic acid (DHA) and eicosapen-taenoic acid (EPA) from less saturated long chain fatty acids (LCFAs) in a lipid composition, wherein said PUFAs and LCFAs are present as (i) triglycerides, or (ii) free fatty acids or monoalkyl esters, by exchange of at least a portion of LCFAs with short and/or medium chain fatty acids (MCFAs). The process can suitably be employed on marine derived oil, marine oil 2 derived oil products and other sources of PUFAs, including PUFA-rich singe cell oils (SCOs), and oils from genetically modified organisms with a modified lipid metabolism. The inventive process is based on novel use of lipases and distillation techniques, selectively chemically modifying species in the substrate material such that the desired species and chemically similar species become sufficiently dissimilar to be separable.Type: ApplicationFiled: June 23, 2011Publication date: August 1, 2013Applicant: EPAX ASInventors: Gudmundur G. Haraldsson, Bjorn Kristinsson
-
Publication number: 20110212183Abstract: The present invention relates to compositions suitable for improving oxidative stability of marine oils, marine oils having improved oxidative stability as well as methods for manufacturing such compositions.Type: ApplicationFiled: August 26, 2009Publication date: September 1, 2011Applicant: EPAX ASInventors: Harald Breivik, Charlotte Jacobsenq, Vidar Moen, Tania Vojnovic
-
Publication number: 20100197785Abstract: The present invention relates to an omega-3 fortified composition, method for its production and use of said composition as a nutritional, food or pharmaceutical composition.Type: ApplicationFiled: July 14, 2008Publication date: August 5, 2010Applicant: EPAX ASInventor: Harald Breivik
-
Publication number: 20100081694Abstract: The present invention relates to compositions comprising at least one peroxisome proliferator-activated receptor (PPAR) agonist and a lipid component and to pharmaceutical ingredients comprising said ingredients. Such compositions are particularly suitable for the prophylaxis and/or the treatment of diseases such as diabetes, obesity and hypertriglyceridemia.Type: ApplicationFiled: September 25, 2009Publication date: April 1, 2010Applicant: EPAX ASInventors: Jan Kopecky, Martin Rossmeisl, Bjorn Refsum